Stocks and Investing Stocks and Investing
Wed, October 17, 2018
Tue, October 16, 2018

Madhu Kumar Upgraded (ABUS) to Strong Buy and Decreased Target to $9 on, Oct 16th, 2018


Published on 2024-10-26 09:33:44 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of B. Riley Securities, Upgraded "Arbutus Biopharma Corporation" (ABUS) to Strong Buy and Decreased Target from $12 to $9 on, Oct 16th, 2018.

Madhu has made no other calls on ABUS in the last 4 months.



There is 1 other peer that has a rating on ABUS. Out of the 1 peers that are also analyzing ABUS, all agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Robert Driscoll of "Wedbush" Upgraded from Sell to Hold and Held Target at $5 on, Monday, October 15th, 2018
Contributing Sources